Immunology
FcRn Inhibition As a Therapeutic Class
FcRn inhibitors in IgG autoimmune disease: targeted therapy transforming treatment of gMG and CIDP with ...
JULY 18, 2026
Intravenous Immunoglobulin In Solid-Organ Transplantation
Antibody management strategies guide evidence based use of IVIG across kidney and lung transplant programs.
JUNE 17, 2026
Clinical Characterization and Multimodal Management Of Pediatric Acute-Onset Neuropsychiatric Syndrome
Pediatric acute-onset neuropsychiatric syndrome overview of diagnosis, clinical features, and multidisciplinary ...
MAY 31, 2026
Pharmacists and Nurses Partner to Smooth Pediatric Ig Therapy
Infusion pharmacists and nurses both play a part in improving the experience of children who receive IV or ...
APRIL 23, 2026
The Role of Intravenous Immunoglobulin Therapy in Dermatomyositis
IVIG in dermatomyositis: evidence-based therapy, safety measures, and strategies to reduce thromboembolic risk for ...
APRIL 1, 2026
Restoring Immune Homeostasis In Long COVID
Immunomodulation research highlights targeted therapy approaches for chronic post COVID inflammatory and vascular ...
JANUARY 26, 2026
Secondary Immunodeficiency: A Growing Healthcare Concern
Secondary immunodeficiency management strategies to reduce infection risk and improve patient outcomes.
DECEMBER 12, 2025
Transitioning Rh Immune Globulin Oversight to Pharmacy Improves Safety, Timeliness, and Consistency
Transitioning oversight of Rho(D) immune globulin from the blood bank to the pharmacy led to improved safety, ...
DECEMBER 8, 2025
Home-Based Ig Rx Reduces Infections And Antibiotic Use
Adults with primary immunodeficiency using home-based immunoglobulin replacement therapy had fewer infections and ...
NOVEMBER 18, 2025
Forging Better Immunoglobulin Outcomes
Two new studies presented at the IgNS 2024 National Conference, in Washington, D.C., offer insight into treatment ...
NOVEMBER 18, 2025
A Deeper Dive Into The New IG Products
New IVIG and subcutaneous immunoglobulin products explained—Alyglo, Asceniv, HyQvia, and ...
NOVEMBER 18, 2025
Immunologic and Anaphylactoid Reactions in Ig Therapy
Immunoglobulin therapy reactions explained—learn mechanisms, severity, and clinical management per IgNS ...
NOVEMBER 17, 2025
